Cognition Therapeutics Inc (CGTX)
1.95
+0.02
(+1.04%)
USD |
NASDAQ |
Apr 26, 16:00
1.945
0.00 (0.00%)
After-Hours: 20:00
Cognition Therapeutics Price to Book Value: 3.107 for April 26, 2024
Price to Book Value Chart
Historical Price to Book Value Data
Date | Value |
---|---|
April 26, 2024 | 3.107 |
April 25, 2024 | 3.076 |
April 24, 2024 | 3.171 |
April 23, 2024 | 3.187 |
April 22, 2024 | 2.964 |
April 19, 2024 | 2.932 |
April 18, 2024 | 2.932 |
April 17, 2024 | 3.028 |
April 16, 2024 | 3.012 |
April 15, 2024 | 3.044 |
April 12, 2024 | 3.123 |
April 11, 2024 | 3.330 |
April 10, 2024 | 3.155 |
April 09, 2024 | 3.235 |
April 08, 2024 | 3.299 |
April 05, 2024 | 3.267 |
April 04, 2024 | 3.076 |
April 03, 2024 | 3.139 |
April 02, 2024 | 2.884 |
April 01, 2024 | 3.028 |
March 28, 2024 | 2.900 |
March 27, 2024 | 2.900 |
March 26, 2024 | 2.916 |
March 25, 2024 | 2.900 |
March 22, 2024 | 2.884 |
Date | Value |
---|---|
March 21, 2024 | 3.012 |
March 20, 2024 | 3.139 |
March 19, 2024 | 2.916 |
March 18, 2024 | 2.964 |
March 15, 2024 | 2.900 |
March 14, 2024 | 2.836 |
March 13, 2024 | 2.385 |
March 12, 2024 | 2.438 |
March 11, 2024 | 2.610 |
March 08, 2024 | 2.610 |
March 07, 2024 | 2.610 |
March 06, 2024 | 2.703 |
March 05, 2024 | 2.783 |
March 04, 2024 | 2.571 |
March 01, 2024 | 2.650 |
February 29, 2024 | 2.743 |
February 28, 2024 | 2.681 |
February 27, 2024 | 2.589 |
February 26, 2024 | 2.589 |
February 23, 2024 | 2.628 |
February 22, 2024 | 2.642 |
February 21, 2024 | 2.615 |
February 20, 2024 | 2.628 |
February 16, 2024 | 2.576 |
February 15, 2024 | 2.602 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.6955
Minimum
Jun 22 2022
3.330
Maximum
Apr 11 2024
1.612
Average
1.388
Median
Oct 05 2023
Price to Book Value Benchmarks
NovaBay Pharmaceuticals Inc | 1.739 |
Palatin Technologies Inc | -- |
iBio Inc | 0.6668 |
Theriva Biologics Inc | 0.1946 |
Oragenics Inc | 2.929 |
Price to Book Value Related Metrics
Price | 1.95 |
Earnings Yield | -44.10% |
Market Cap | 76.05M |